Epitope analysis of the Goodpasture antigen using a resonant mirror biosensor

Clinical and Experimental Immunology

Volumn 106, Issue 1, 1996, Pages 79-85

  Levy, J B ^a   Turner, A N ^b   George, A J T ^a   Pusey, C D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anti GBM disease; Biosensor; Epitope mapping; Goodpasture's disease

Indexed keywords

AUTOANTIGEN; RECOMBINANT PROTEIN;

ARTICLE; B LYMPHOCYTE; BIOSENSOR; CLINICAL ARTICLE; EPITOPE MAPPING; GOODPASTURE SYNDROME; HUMAN; PRIORITY JOURNAL;

EID: 0029758824     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-815.x     Document Type: Article

References (29)

1. Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 1967; 126:989-1004.
2. Simpson IJ, Doak PB, Williams LC et al. Plasma exchange in Goodpasture's syndrome. Am J Nephrol 1982; 2:301-11.
3. Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980 4. Br Med J 1986; 292:301 4.
4. Dixon FJ, McPhaul JJ, Lerner RA. The contribution of kidney transplantation to the study of glomerulonephritis - the recurrence of glomerulonephritis in renal transplants. Transplant Proc 1969; 1:194 6.
5. Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG. Identilication of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J. Biol Chem 1988; 263:13374-80.
6. Hudson BG, Wieslander J, Wisdom B Jr. Noelken ME. Goodpasture syndrome: molecular architecture and function of basement membrane antigen [published erratum appears in Lab Invest 1989 Dec; 61:690]. Lab Invest 1989; 61:256-69.
7. Turner N, Mason PJ, Brown R et al. Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 1992; 89:592 601.
8. Kalluri R, Gunwar S, Reeders ST et al. Goodpasture syndrome. Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3(IV) chain of basement membrane collagen. J Biol Chem 1991; 266:24018 24.
9. Penades JR, Bernai D, Revert F et al. Characterisation and expression of multiple alternatively spliced transcripts of the Goodpasture antigen gene region. Eur J Biochem 1995; 229:754 60.
10. Levy JB, Coulthart A, Pusey CD. Epitope studies on the Goodpasture antigen. J Am Soc Nephrol 1995; 6:839.
11. Morrison KE, Mariyama M, Yang-Feng TL, Reeders ST. Sequence and localisation of a partial cDNA encoding the human a3 chain of type IV collagen. Am J Hum Genet 1991; 49:545 54.
12. Mariyama M, Zheng K, Yang-Feng TL, Reeders ST. Colocalisation of the genes for the a3(IV) and a4(IV) chains of type IV collagen to Chromosome 2 bands q35-q37. Genomics 1992; 13:809 13.
13. Neilson EG, Kalluri R, Sun MJ et al. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen. J Biol Chem 1993; 268:8402 5.
14. Turner N, Forstova J, Rees A, Pusey CD, Mason PJ. Production and characterisation of recombinant Goodpasture antigen from insect cells. J Biol Chem 1994; 269:17141 5.
15. Vagdama P, Crump PW. Biosensors: recent trends. Analyst 1992; 117;1657.
16. Hodgson J, Light, angles, action. Instruments for label-free, real-time monitoring of intermolecular interactions. Bio Technology 1994; 12:31.
17. Karlsson R, Michaelsson A, Mattsson L. Kinetic analysis of monoclonal antibody antigen interactions with a new biosensor based analytical system. J Immunol Methods 1991; 145:229-40.
18. Altschuh D, Dubs MC, Weiss E, Zeder-Lutz G, Van-Regenmortel MH. Determination of kinetic constants for the interaction between a monoclonal antibody and peptides using surface plasmon resonance. Biochemistry 1992; 31:6298 304.
19. Malmborg AC, Michaelsson A, Ohlin M, Jansson B, Borrebaeck CA. Real time analysis of antibody antigen reaction kinetics. Scand J Immunol 1992; 35:643 50.
20. George AJT, French RR, Glennie MJ. Measurement of kinetic binding constants of a panel of anti-saporin antibodies using a resonant mirror biosensor. J Immunol Methods 1995; 183:51-63.
21. Cush R, Cronin JM, Stewart WJ, Maule CH, Molloy J, Goddard NJ. The resonant mirror: a novel optical biosensor for direct sensing of biomolecular interactions. Part 1: Principles of operation and associated instrumentation. Biosens Bioelectron 1993; 8:347-53.
22. Katbamna I, Turner N, Ross CN, Pusey CD. Development and application of an ELISA for Goodpasture's disease based on sheep a3(IV)NC1 domains. J Clin Lab Immunol 1996; (in press).
23. Buckle PE, Davies RJ, Kinning T et al. The resonant mirror: a novel optical biosensor for direct sensing of biomolecular interactions. Part II: Applications. Biosens Bioelectron 1993; 8:355-68.
24. George AJT, Jamar F, Tai M et al. Radiometal labeling of recombinant proteins by a genetically engineered, minimal chelation site: coordination of technetium-99m by single chain Fv antibody fusion proteins through a carboxyl-terminal cysteinyl peptide. Proc Natl Acad Sci USA 1995; 92:8358-62.
25. George AJT, Danga R, Gooden CRS, Epenetos AA, Spooner RA. Quantitative and qualitative detection of serum antibodies using a resonant mirror biosensor. Tumour Targeting 1995; 1:1-6.
26. Pusey CD, Dash A, Kershaw MJ et al. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane. Lab Invest 1987; 56:23-31.
27. Derry CJ, Dunn MJ, Rees AJ, Pusey CD. Restricted specificity of the autoantibody response in goodpasture's syndrome demonstrated by two-dimensional Western blotting. Clin Exp Immunol 1991;86:457-63.
28. Helimark T, Johansson C, Wieslander J. Characterisation of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int 1995; 46:823-9.
29. Turner N, Ryan J, Phelps R, Rees AJ. B cell epitopes of the Goodpasture antigen. J Am Soc Nephrol 1995; 6:856.